BiondVax Pharmaceuticals Probability of Future Stock Price Finishing Over 1.28

BVXVDelisted Stock  USD 1.35  0.03  2.17%   
BiondVax Pharmaceuticals' future price is the expected price of BiondVax Pharmaceuticals instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of BiondVax Pharmaceuticals performance during a given time horizon utilizing its historical volatility. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
  
Please specify BiondVax Pharmaceuticals' target price for which you would like BiondVax Pharmaceuticals odds to be computed.

BiondVax Pharmaceuticals Target Price Odds to finish over 1.28

The tendency of BiondVax Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to stay above $ 1.28  in 90 days
 1.35 90 days 1.28 
more than 93.0
Based on a normal probability distribution, the odds of BiondVax Pharmaceuticals to stay above $ 1.28  in 90 days from now is more than 93.0 (This BiondVax Pharmaceuticals probability density function shows the probability of BiondVax Stock to fall within a particular range of prices over 90 days) . Probability of BiondVax Pharmaceuticals price to stay between $ 1.28  and its current price of $1.35 at the end of the 90-day period is nearly 4.66 .
Given the investment horizon of 90 days BiondVax Pharmaceuticals has a beta of -0.13 suggesting as returns on the benchmark increase, returns on holding BiondVax Pharmaceuticals are expected to decrease at a much lower rate. During a bear market, however, BiondVax Pharmaceuticals is likely to outperform the market. Additionally BiondVax Pharmaceuticals has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   BiondVax Pharmaceuticals Price Density   
       Price  

Predictive Modules for BiondVax Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as BiondVax Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of BiondVax Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
1.351.351.35
Details
Intrinsic
Valuation
LowRealHigh
1.281.281.49
Details

BiondVax Pharmaceuticals Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. BiondVax Pharmaceuticals is not an exception. The market had few large corrections towards the BiondVax Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold BiondVax Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of BiondVax Pharmaceuticals within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.64
β
Beta against Dow Jones-0.13
σ
Overall volatility
0.24
Ir
Information ratio -0.18

BiondVax Pharmaceuticals Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of BiondVax Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for BiondVax Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
BiondVax Pharmaceuticals is not yet fully synchronised with the market data
BiondVax Pharmaceuticals may become a speculative penny stock
BiondVax Pharmaceuticals has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (5.8 M) with profit before overhead, payroll, taxes, and interest of 0.
BiondVax Pharmaceuticals currently holds about 14.55 M in cash with (7.26 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.23, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Roughly 20.0% of the company shares are held by company insiders

BiondVax Pharmaceuticals Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of BiondVax Stock often depends not only on the future outlook of the current and potential BiondVax Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. BiondVax Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding754.1 B
Cash And Short Term Investments14.1 M

BiondVax Pharmaceuticals Technical Analysis

BiondVax Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. BiondVax Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of BiondVax Pharmaceuticals. In general, you should focus on analyzing BiondVax Stock price patterns and their correlations with different microeconomic environments and drivers.

BiondVax Pharmaceuticals Predictive Forecast Models

BiondVax Pharmaceuticals' time-series forecasting models is one of many BiondVax Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary BiondVax Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about BiondVax Pharmaceuticals

Checking the ongoing alerts about BiondVax Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for BiondVax Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
BiondVax Pharmaceuticals is not yet fully synchronised with the market data
BiondVax Pharmaceuticals may become a speculative penny stock
BiondVax Pharmaceuticals has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (5.8 M) with profit before overhead, payroll, taxes, and interest of 0.
BiondVax Pharmaceuticals currently holds about 14.55 M in cash with (7.26 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.23, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Roughly 20.0% of the company shares are held by company insiders
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Consideration for investing in BiondVax Stock

If you are still planning to invest in BiondVax Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BiondVax Pharmaceuticals' history and understand the potential risks before investing.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Commodity Directory
Find actively traded commodities issued by global exchanges